A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection

Annals of Surgery

Volumn 244, Issue 6, 2006, Pages 921-928

  Petrowsky, Henrik ^a   McCormack, Lucas ^a   Trujillo, Martha ^a   Selzner, Markus ^a   Jochum, Wolfram ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; BILE DUCT CARCINOMA; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GALLBLADDER CARCINOMA; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; INTERMITTENT PORTAL TRIAD CLAMPING; ISCHEMIC PRECONDITIONING WITH CONTINUOUS CLAMPING; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER HYDATID CYST; LIVER INJURY; LIVER ISCHEMIA; LIVER METASTASIS; LIVER PROTECTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; OPERATION DURATION; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

AGE FACTORS; AGED; CONSTRICTION; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PORTAL SYSTEM; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33751351636     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000246834.07130.5d     Document Type: Article

References (38)

1. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
2. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406; discussion 406-407.
3. Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698-708; discussion 708-710.
4. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg. 2003;237:860-869; discussion 869-870.
5. Tsao JI, Loftus JP, Nagorney DM, et al. Trends in morbidity and mortality of hepatic resection for malignancy: a matched comparative analysis. Ann Surg. 1994;220:199-205.
6. Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994;115:303-309.
7. Pringle J. Note on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48:501.
8. Clavien PA, Yadav S, Sindram D, et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155-162.
9. Lesurtel M, Selzner M, Petrowsky H, et al. How should transection of the liver be performed? A prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg. 2005;242:814-822, discussion 822-823.
10. Huguet C, Nordlinger B, Bloch P, et al. Tolerance of the human liver to prolonged normothermic ischemia: a biological study of 20 patients submitted to extensive hepatectomy. Arch Surg. 1978;113:1448-1451.
11. Melendez JA, Arslan V, Fischer ME, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998;187:620-625.
12. Bhattacharya S, Jackson DJ, Beard CI, et al. Central venous pressure and its effects on blood loss during liver resection. Br J Surg. 1999;86:282-283.
13. Nakajima Y, Shimamura T, Kamiyama T, et al. Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today. 2002;32:48-52.
14. Wei AC, Tung-Ping Poon R, Fan ST, et al. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg. 2003;90:33-41.
15. Selzner N, Rudiger H, Graf R, et al. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917-936.
16. Isozaki H, Adam R, Gigou M, et al. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg. 1992;79:310-313.
17. Hewitt G, Halliday I, McCaigue M, et al. Mortality, endotoxaemia and cytokine expression after intermittent and continuous hepatic ischaemia. Br J Surg. 1995;82:1424-1426.
18. Rudiger HA, Kang KJ, Sindram D, et al. Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg. 2002;235:400-407.
19. Kang KJ, Jang JH, Lim TJ, et al. Optimal cycle of intermittent portal triad clamping during liver resection in the murine liver. Liver Transpl. 2004;10:794-801.
20. Peralta C, Bartrons R, Riera L, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol. 2000;279:G163-G171.
21. Selzner N, Selzner M, Jochum W, et al. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J Hepatol. 2003;39:55-61.
22. Belghiti J, Noun R, Malafosse R, et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg. 1999;229:369-375.
23. Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238:843-850; discussion 851-852.
24. Li SQ, Liang LJ, Huang JF, et al. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol. 2004;10:2580-2584.
25. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
26. Peralta C, Closa D, Hotter G, et al. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun. 1996;229:264-270.
27. Yadav SS, Sindram D, Perry DK, et al. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology. 1999;30:1223-1231.
28. Rudiger HA, Graf R, Clavien PA. Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver. J Hepatol. 2003;39:972-977.
29. Makuuchi M, Mori T, Gunven P, et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987;164:155-158.
30. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
31. Barrier A, Olaya N, Chiappini F, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J. 2005;19:1617-1626.
32. Behrns KE, Tsiotos GG, DeSouza NF, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2:292-298.
33. Kooby DA, Fong Y, Suridwinata A, et al. J Gastrointest Surg. 2003;7:1034-1044.
34. Nakayama H, Masuda H, Shibata M, et al. Incidence of bile leakage after three types of hepatic parenchymal transection. Hepatogastroenterology. 2003;50:1517-1520.
35. Nagano Y, Togo S, Tanaka K, et al. Risk factors and management of bile leakage after hepatic resection. World J Surg. 2003;27:695-698.
36. Tanaka S, Hirohashi K, Tanaka H, et al. Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J Am Coll Surg. 2002;195:484-489.
37. Asahara T, Katayama K, Itamoto T, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg. 1999;23:676-680.
38. van der Bilt JD, Kranenburg O, Nijkamp MW, et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology. 2005;42:165-175.